Tempest Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Tempest Therapeutics, Inc. (TPST) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.28 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-19.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-03-19
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $7.28M.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-12-31 was $0.00.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $73.00K.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $7.28M, a 9873.97% increase from fiscal 2021.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $73.00K.
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $99.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.28M 10-K · filed 2024-03-19 | |||
| 2022-06-30 | $7.28M 10-Q · filed 2023-11-08 | $7.28M 10-Q · filed 2022-08-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $73.00K derived: sum of 2 quarters · filed 2023-03-22 | $73.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $73.00K 10-Q · filed 2022-11-08 | $73.00K 10-Q · filed 2021-11-10 | ||
| 2018-12-31 | $99.00K 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |